BioRestorative Therapies Investor Relations Material

BioRestorative Therapies Inc is a biotechnology company focused on developing regenerative medicine therapies, particularly for musculoskeletal and metabolic conditions. The company’s research centers on stem cell-based treatments designed to address chronic lower back pain, degenerative disc disease, and metabolic disorders. BioRestorative Therapies leverages its proprietary stem cell platforms to create potential therapeutic options that aim to repair and regenerate damaged tissues, supporting patients with limited treatment alternatives. The company is headquartered in Melville, New York, and its shares are listed on the NASDAQ.